Europe's leading congress on skin and sexual health
Paris 17-20 September 2025
The EADV Congress is an international meeting focused on dermatology and venereology, providing a platform for researchers, clinicians, and industry professionals to exchange knowledge, network, and present their latest research findings.


Welcome letter from the President
Prof. Branka Marinovic


Welcome letter from the SPC Chair
Prof. Michel Gilliet
Thank you for joining the biggest EADV Congress yet!
With more than 20,000 delegates joining us, this week has been filled with knowledge, exchange, and unforgettable connections. A heartfelt thank you to our delegates, speakers, and the dedicated staff who made this Congress possible.
Together, we turned Paris into a hub of science, collaboration, and community.
Post-event information
EADV Congress 2025: Press Releases and Scientific spotlights


Psoriasis linked to increased risk of vision-threatening eye disease, study finds
EADV Congress 2025 Press Release
New research presented at the EADV Congress 2025 reveals that people with psoriasis face a significantly increased risk of developing age-related macular degeneration (AMD), a


GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
EADV Congress 2025 Press Release
Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events


Beyond the surface: Atopic eczema linked to significantly higher risk of suicidal thoughts, major study finds
EADV Congress 2025 Press Release
A new international study presented at the EADV Congress 2025 reveals that adults with atopic eczema are significantly more likely to experience suicidal thoughts, with


EADV Congress 2025 keynote lecture
Live like a sloth, think like an octopus
Lessons from nature’s greatest survivors
In this fascinating talk the best-selling author, broadcaster and zoologist Lucy Cooke exposes how unconscious


Bullous Diseases
Bullous Diseases: Diagnosis, Challenges & Advances
Join us for an insightful exploration into the world of bullous skin diseases, featuring expert-led presentations and real-world clinical insights.
Why to


Psoriasis
Recent advances in psoriasis treatment focus on personalized approaches, emphasizing early and aggressive intervention with IL-17/IL-23 inhibitors and novel small molecules to achieve long-term remission, though treatment resistance remains a


Dermoscopy for non-melanoma skin cancer
Hair and nail dermoscopy highlights the diagnostic value of dermoscopy in identifying inflammatory nail diseases like psoriasis and lichen planus, which show distinct patterns such as pitting, onycholysis, or dorsal


Hair disorders: Management
This session explores two challenging types of alopecia: androgenetic alopecia (AGA) and neutrophilic scarring alopecias, including dissecting cellulitis (DC) and folliculitis decalvans (FD). Experts will review the latest in diagnosis,


Skin microbiome: its role in acne and hidradenitis suppurativa
In this presentation, we explore how skin microbiome dysbiosis contributes to acne and hidradenitis suppurativa (HS). Acne involves C. acnes phylotype IA1 dominance and S. epidermidis imbalance, while HS is


Nail disorders
This presentation reviews topical, intralesional, systemic, biologic and small molecules treatments, outlining indications based on the site and severity of nail involvement.